CD8A and neoplasm: In contrast, the D1-1 short peptide induced a strong peptide-specific response in IFN-γ ELISPOT assay, however, the peptide failed to induce cytotoxicity of either CD3 or CD8 T cells against peptide-pulsed autologous DCs and several tumor cells lines that highly express cyclin D-1.